Testing effectiveness (Phase 2)Active Not RecruitingNCT02008656
What this trial is testing
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
Who this might be right for
Rectal Cancer
Memorial Sloan Kettering Cancer Center 358